Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice.

Nakamura A, Mori Y, Hagiwara K, Suzuki T, Sakakibara T, Kikuchi T, Igarashi T, Ebina M, Abe T, Miyazaki J, Takai T, Nukiwa T.

J Exp Med. 2003 Mar 3;197(5):669-74.

PMID:
12615907
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli.

Henriksen PA, Hitt M, Xing Z, Wang J, Haslett C, Riemersma RA, Webb DJ, Kotelevtsev YV, Sallenave JM.

J Immunol. 2004 Apr 1;172(7):4535-44.

PMID:
15034071
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages.

Ding A, Thieblemont N, Zhu J, Jin F, Zhang J, Wright S.

Infect Immun. 1999 Sep;67(9):4485-9.

PMID:
10456890
[PubMed - indexed for MEDLINE]
Free PMC Article
5.
6.
7.
8.
9.

Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor.

Zhu J, Nathan C, Ding A.

Biochim Biophys Acta. 1999 Sep 21;1451(2-3):219-23.

PMID:
10556576
[PubMed - indexed for MEDLINE]
Free Article
10.

Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.

Jin FY, Nathan C, Radzioch D, Ding A.

Cell. 1997 Feb 7;88(3):417-26.

PMID:
9039268
[PubMed - indexed for MEDLINE]
Free Article
11.

Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.

Taggart CC, Greene CM, McElvaney NG, O'Neill S.

J Biol Chem. 2002 Sep 13;277(37):33648-53. Epub 2002 Jun 25.

PMID:
12084717
[PubMed - indexed for MEDLINE]
Free Article
12.

Identification of genes involved in innate responsiveness to bacterial products by differential display.

Jin F, Nathan C, Ding A.

Methods. 1998 Dec;16(4):396-406.

PMID:
10049647
[PubMed - indexed for MEDLINE]
13.

Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.

Mulligan MS, Lentsch AB, Huber-Lang M, Guo RF, Sarma V, Wright CD, Ulich TR, Ward PA.

Am J Pathol. 2000 Mar;156(3):1033-9.

PMID:
10702419
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.

Taggart CC, Cryan SA, Weldon S, Gibbons A, Greene CM, Kelly E, Low TB, O'neill SJ, McElvaney NG.

J Exp Med. 2005 Dec 19;202(12):1659-68. Epub 2005 Dec 13.

PMID:
16352738
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A neutrophil elastase inhibitor, sivelestat, reduces lung injury following endotoxin-induced shock in rats by inhibiting HMGB1.

Hagiwara S, Iwasaka H, Togo K, Noguchi T.

Inflammation. 2008 Aug;31(4):227-34. doi: 10.1007/s10753-008-9069-z.

PMID:
18536984
[PubMed - indexed for MEDLINE]
16.

ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock.

Tumurkhuu G, Koide N, Hiwasa T, Ookoshi M, Dagvadorj J, Abu Shadat Mohammod Noman, Iftakhar-E-Khuda I, Naiki Y, Komatsu T, Yoshida T, Yokochi T.

Innate Immun. 2011 Feb;17(1):97-105. doi: 10.1177/1753425909353641. Epub 2009 Dec 18.

PMID:
20023007
[PubMed - indexed for MEDLINE]
17.

Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.

van Wetering S, van der Linden AC, van Sterkenburg MA, Rabe KF, Schalkwijk J, Hiemstra PS.

J Investig Med. 2000 Sep;48(5):359-66.

PMID:
10979241
[PubMed - indexed for MEDLINE]
18.

Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.

Sallenave JM, Shulmann J, Crossley J, Jordana M, Gauldie J.

Am J Respir Cell Mol Biol. 1994 Dec;11(6):733-41.

PMID:
7946401
[PubMed - indexed for MEDLINE]
19.

Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia.

Grobmyer SR, Barie PS, Nathan CF, Fuortes M, Lin E, Lowry SF, Wright CD, Weyant MJ, Hydo L, Reeves F, Shiloh MU, Ding A.

Crit Care Med. 2000 May;28(5):1276-82.

PMID:
10834665
[PubMed - indexed for MEDLINE]
20.

Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.

Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, Bernsmeier C, Mitry RR, O'Brien A, Gilroy D, Goldin R, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Thursz M.

Hepatology. 2014 Apr;59(4):1564-76. doi: 10.1002/hep.26933. Epub 2014 Feb 28.

PMID:
24282114
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk